Can Biosimilar Orphans Increase Health System Sustainability In The UK?

 
• By Francesca Bruce

Developing biosimilar orphan drugs is fraught with challenges and needs buy-in from regulators, developers, patients and clinicians.

Carrot By Billion Photos
Incentives are needed to stimulate development of orphan medicines • Source: Shutterstock

More from Europe

More from Geography